Loading stock data…
$114.11-2.15 (-1.85%)
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$29.55M↑ | -$29.71M↓ | -$22.75M↓ | -$19.82M↓ | -$16.07M |
| Net Income | -$23.50M↑ | -$27.23M↓ | -$21.85M↓ | -$20.10M↓ | -$15.64M |
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The compan...